Xcout Intel
Kit Check
Kit Check (operating as Bluesight) provides AI-enabled software and RFID technology solutions for hospital and pharmacy operations. Its platform automates inventory tracking, drug diversion surveillance, purchasing optimization, 340B compliance, drug shortage management, and patient privacy monitoring to help healthcare organizations improve efficiency and compliance.
Subscribe to see Kit Check’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Kit Check at a glance
Kit Check is a healthtech company headquartered in United States. Its most recent funding round, Series C, raised $15.1M in June 2016. Xcout tracks 8 named people at Kit Check, including Mark Peters (Chief Financial Officer).
Kit Check leadership
- Mark PetersChief Financial Officer
- Vijay VenkateshChief Technology Officer
- Jason Vander MeerChief Product Officer
- Matt McAluneyChief Revenue Officer
- Kevin MacDonaldCo-Founder and CEO
- Amy SchartnerVP, People
2 more named people on record for Kit Check, with roles, board committees and tenure — see the full roster →
Kit Check funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $15.1M | 3 named | |
| SEC Form D filing | $2.7M | — | |
| Series B | $12M | — | |
| Series B | $3.2M | — | |
| Series A | $10.4M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Kit Check competitors
A few of Kit Check's closest competitors — see the full list of competitors and alternatives →
Bluesight is a healthcare technology company that provides medication-management and intelligence software for hospitals and health systems. Its platform supports pharmacy inventory management, medication-use optimization, and controlled-substance diversion prevention.
MedEdge LLC provides software and data intelligence platforms specifically designed for infusion and specialty pharmacies. Its services include data integration via its Mosaic platform, automated 340B compliance management, and automated pharmacy licensure verification to help pharmacies reduce operational risk and manual workflows.
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Best Health Solutions provides an end-to-end medication management software platform for aged care providers, pharmacies, and clinicians in Australia.
RxSense is a healthcare technology company headquartered in Boston, transforming the delivery of pharmacy benefits. It provides clearer insights and intuitive tools to help clients reduce manual work, make faster decisions, and enhance the overall experience for plan members.
Get Kit Check's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Kit Check in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 5 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access